Agilent Technologies Inc: (NYSE: A)

$45.99

2.02 (4.59%)

Volume 3,690,081

May 15 10:39 AM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Company News

Get Company News for:

News For A

May 15, 2013 Agilent Technologies Reports Decline in Q2 Profit - Benzinga

May 15, 2013 Agilent Technology Beats Q2 Estimate but Outlook Disappoints (A) - DailyStocks

May 15, 2013 Frost & Sullivan Recognizes Agilent's Dominance in the Global RF Test Equipment Market - Pr Newswire

May 15, 2013 Frost & Sullivan Recognizes Agilent's Dominance in the Global RF Test Equipment Market - Pr Newswire Europe

May 15, 2013 PreMarket Info Recap for May 15, 2013 - Benzinga

May 15, 2013 UPDATE: ISI Group Raises PT on Agilent Technologies on Mixed Factors - Benzinga

May 15, 2013 UPDATE: Stifel Nicolaus Raises PT on Agilent Technologies Following F2Q13 Results - Benzinga

May 14, 2013 Agilent Tech Q2 Net Drops, Job Cuts and Share Repurchase Widening Announced - TheMotleyFool

May 14, 2013 Agilent Technologies Narrows Guidance Below Estimates - Earningswhispers Earnings Guidance

May 14, 2013 Agilent Technologies Reports Second-Quarter 2013 Results, Increases Stock Repurchase Program to $1 Billion - Businesswire

May 14, 2013 Agilent Technologies, Inc.Corporate Event Announcement Notice - Wall Street Horizon

May 14, 2013 Agilent to cut jobs after profits drop - Mcclatchy-Tribune Information Services -- Unrestricted

Zacks Commentary For A

May 15, 2013 Zacks Blog: Agilent Sees Persistent Weakness in 2013

May 14, 2013 Zacks Blog: City of Olympia Choses Itron's AMI Solution

May 13, 2013 Zacks Blog: Will Agilent Beat Earnings Ests in 2Q?

May, 10 2013 00:00 Zacks Earnings Preview: Focus Shifts to Retail Earnings

Apr 29, 2013 Zacks Blog: Roper's 1Q Earnings Beat

Apr 29, 2013 Zacks Blog: Itron Misses Earnings Est. in 1Q

Apr 19, 2013 Zacks Blog: Roper Expands in Medical Segment

Apr 18, 2013 Zacks Blog: Texas Instruments Lab at UC Berkeley

Apr 10, 2013 Zacks Blog: Itron's AMI Solution Fully Utilized

Apr 09, 2013 Zacks Blog: Agilent Upgrades Oscilloscopes

Apr 08, 2013 Zacks Blog: FDA Approves Agilent's Clone EP1

Mar 19, 2013 Zacks Blog: TXN's New Evaluation Kit

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.